BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 12403639)

  • 1. Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitus.
    Dunn CJ; Plosker GL
    Pharmacoeconomics; 2002; 20(14):989-1025. PubMed ID: 12403639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus.
    Wilde MI; McTavish D
    Drugs; 1997 Oct; 54(4):597-614. PubMed ID: 9339963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus.
    Chapman TM; Noble S; Goa KL
    Drugs; 2002; 62(13):1945-81. PubMed ID: 12215068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of severe hypoglycaemia in patients with type 1 diabetes in Spain and the cost-effectiveness of insulin lispro compared with regular human insulin in preventing severe hypoglycaemia.
    Reviriego J; Gomis R; Marañés JP; Ricart W; Hudson P; Sacristán JA
    Int J Clin Pract; 2008 Jul; 62(7):1026-32. PubMed ID: 18489577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic value of a new insulin preparation, Humalog Mix 25. Measured by a willingness-to-pay approach.
    Dranitsaris G; Longo CJ; Grossman LD
    Pharmacoeconomics; 2000 Sep; 18(3):275-87. PubMed ID: 11147394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin lispro, a new insulin analog.
    Kucera ML; Graham JP
    Pharmacotherapy; 1998; 18(3):526-38. PubMed ID: 9620104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of insulin lispro versus neutral (regular) insulin therapy using a willingness-to-pay approach.
    Davey P; Grainger D; MacMillan J; Rajan N; Aristides M; Dobson M
    Pharmacoeconomics; 1998 Mar; 13(3):347-58. PubMed ID: 10178660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of insulin analogues for diabetes mellitus.
    Cameron CG; Bennett HA
    CMAJ; 2009 Feb; 180(4):400-7. PubMed ID: 19221353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy. The UK Trial Group.
    Gale EA
    Diabet Med; 2000 Mar; 17(3):209-14. PubMed ID: 10784225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures.
    Roach P; Woodworth JR
    Clin Pharmacokinet; 2002; 41(13):1043-57. PubMed ID: 12403642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin lispro: a review of its use in the management of diabetes mellitus.
    Simpson D; McCormack PL; Keating GM; Lyseng-Williamson KA
    Drugs; 2007; 67(3):407-34. PubMed ID: 17335298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Premixed insulin analogues for the treatment of diabetes mellitus.
    Garber AJ
    Drugs; 2006; 66(1):31-49. PubMed ID: 16398567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin therapy in diabetes mellitus: how can the currently available injectable insulins be most prudently and efficaciously utilised?
    Bell DS
    Drugs; 2007; 67(13):1813-27. PubMed ID: 17722952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An estimation of the long-term clinical and economic benefits of insulin lispro in Type 1 diabetes in the UK.
    Pratoomsoot C; Smith HT; Kalsekar A; Boye KS; Arellano J; Valentine WJ
    Diabet Med; 2009 Aug; 26(8):803-14. PubMed ID: 19709151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin lispro: a useful advance in insulin therapy.
    Heller S
    Expert Opin Pharmacother; 2003 Aug; 4(8):1407-16. PubMed ID: 12877647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.
    Giugliano D; Ceriello A; Razzoli E; Esposito K
    Clin Drug Investig; 2008; 28(4):199-210. PubMed ID: 18345710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoglycaemia, analogue insulins; prescribing cost or quality of life?
    Hitman GA
    Diabet Med; 2012 Mar; 29(3):289. PubMed ID: 22364579
    [No Abstract]   [Full Text] [Related]  

  • 20. The human insulin analogue insulin lispro.
    Koivisto VA
    Ann Med; 1998 Jun; 30(3):260-6. PubMed ID: 9677011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.